THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) provides a clarification on the occurrence of increased liver enzymes in patients treated with the 50 mg dose of Proellex®.
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) provides a clarification on the occurrence of increased liver enzymes in patients treated with the 50 mg dose of Proellex®.
